publication venue for
- Utilization and outcomes of metastasectomy for patients with metastatic urothelial cancer: An analysis of the national cancer database.. 40:61.e21-61.e28. 2022
- Pseudouridine as a novel biomarker in prostate cancer.. 39:63-71. 2021
- Intratumor heterogeneity in prostate cancer.. 36:349-360. 2018
- CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species.. 34:337.e11-337.e18. 2016
- Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment.. 33:267.e1-267.13. 2015
- Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder.. 37:492-502.
- miR-301a expression: Diagnostic and prognostic marker for prostate cancer.. 36:503.e9-503.e15.